I call the meeting to order.
Welcome to meeting number 10 of the House of Commons Standing Committee on Health. Today, we will be meeting until about 6 p.m. eastern to hear from witnesses on our study of Canada's health workforce. I understand that Dr. Tomblin Murphy has to leave at 5:40, so I would encourage those who have questions for Dr. Tomblin Murphy to pose those questions before then.
Today's meeting is taking place in a hybrid format, pursuant to the House order of November 25, 2021. All members of the committee are present in the room, but the witnesses are on the Zoom application. For those of you who are using the Zoom application, please do not take any photos of your screen or screenshots.
We will be respecting all of the health care directives from the Board of Internal Economy and the public health authorities.
I can inform the members of the committee that all of our witnesses today have completed the required connection tests in advance of the meeting.
To our witnesses, first let me say, welcome. Each organization will be given five minutes to make its opening statement before the rounds of questions.
Colleagues, we have with us today Geraldine Vance, chief executive officer of the British Columbia Pharmacy Association. From the Canadian Nurses Association, we have Michael Villeneuve, chief executive officer, and Dr. Gail Tomblin Murphy, who is the vice-president of research, innovation and discovery, and is also the chief nurse executive for Nova Scotia Health. From the Kingston Health Sciences Centre, we have Dr. David Pichora, president and CEO. From the Ontario Medical Association, we have Dr. Adam Kassam, president, and Dr. James Wright, chief of economics, policy and research.